{"id":"W4283784137","doi":"10.1016/j.annonc.2022.04.139","title":"P-49 GOBLET: A phase 1/2 multiple indication signal finding and biomarker study in advanced gastrointestinal cancers treated with pelareorep and atezolizumab – safety and preliminary response results","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; Merck","keywords":"Oncolytic virus; Medicine; Atezolizumab; Immunotherapy; Microsatellite instability; Cancer research; Tumor microenvironment; Cancer; DNA mismatch repair; Biomarker; Immunology; Colorectal cancer; Internal medicine; Tumor cells; Biology; Microsatellite; Gene; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001249757,0.001127903,0.001418088,0.0003883942,0.0002725,0.001192797,0.0005709091,0.001303044,0.002336349],"category_scores_gemma":[0.0007560199,0.0003680556,0.001884528,0.0003242772,0.0009629417,0.0008733843,0.000368519,0.002915733,0.0007791916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008855719,"about_ca_system_score_gemma":0.0008858902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006957156,"about_ca_topic_score_gemma":0.001688551,"domain_scores_codex":[0.9996462,0.0001279341,0.00001347808,0.00007070814,0.00005289522,0.00008874973],"domain_scores_gemma":[0.9996089,0.0000659342,0.00007634619,0.00004356942,0.00003366161,0.0001716261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4745935,0.04390731,0.0282622,0.001025008,0.003999917,0.000945619,0.0003970919,0.005059309,0.1895483,0.0007846248,0.009040955,0.2424361],"study_design_scores_gemma":[0.4042481,0.5024909,0.05332155,0.00007722747,0.00283006,0.001618117,0.0001600486,0.003790268,0.02025246,0.0009412175,0.01016828,0.000101709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939258,0.001611696,0.0005783627,0.0008044493,0.00007490176,0.0007380848,0.0008671071,0.0001150234,0.001284596],"genre_scores_gemma":[0.9880911,0.001639608,0.00206216,0.001272365,0.0001270674,0.001097789,0.003450243,0.00007024324,0.002189412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002336349,"threshold_uncertainty_score":0.007815897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04292710352985314,"score_gpt":0.3774572383823815,"score_spread":0.3345301348525284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}